ONL Therapeutics secures $65M in Series D funding to advance innovative retinal treatments, focusing on protecting vision from diseases like AMD.
Read PostNews
Stay up-to-date on the latest industry, member, & policy related news.
Share your News
MichBio members can submit news to be shared here, on our social media, and in our monthly newsletter.
Discover MichBio's latest news on the new TCET coverage pathway, expediting Medicare for FDA-approved devices. Stay informed on bioscience...
Read PostStay informed on MichBio's advocacy for drug price negotiations under the Inflation Reduction Act, impacting Medicare and innovation in the biotech...
Read PostJoin MichBio in advocating for Pharmacy Benefit Manager reforms to enhance patient access to affordable medications. Stay informed on bioscience...
Read PostDiscover TransPharm Preclinical Solutions, a leader in infectious disease research based in Jackson, MI, delivering high-quality data globally since...
Read PostJoin MichBio at the 2024 BIO International Convention, showcasing Michigan's bioscience innovations and fostering global partnerships in the industry.
Read PostJoin MichBio at the SelectUSA Investment Summit to explore Michigan's life sciences opportunities and connect with global investors. Discover...
Read PostDiscover MichBio's advocacy against proposed USPTO rules that threaten patent integrity and innovation in the bio-industry. Stay informed and engaged!
Read Post